TREX 44.45 Trex Company $TREX Hit a 52 week high of 44.53

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 1:46 PM

TREX 44.45 Trex Company $TREX Hit a 52 week high of 44.53 Currently at 44.45 +0.45 +1.02% With a day low of 43.97 and a total volume of 21,433.

TREX Trex Company Recent Headline News

Headwaters Beats Q4 Earnings Estimates on Organic Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 33 mins ago
Headwaters Incorporated (HW) reported fourth-quarter fiscal 2014 earnings per share of 37 cents, a 28% increase from 29 cents in the prior-year quarter.
CBI: 54.94 (-0.64), TREX: 43.88 (-0.12), HW: 13.10 (-0.03), MTZ: 25.50 (-3.13)

Tutor Perini Tops Q3 Earnings on Volume Growth, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:50AM CST
Tutor Perini's (TPC) third-quarter 2014 earnings beat the Zacks Consensus Estimate.
PWR: 33.81 (-0.11), TREX: 43.88 (-0.12), TPC: 26.97 (-0.28), SHW: 236.23 (+0.19)

Fastenal Sales Up, Margins Soft: Should You Invest? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:24PM CST
On Nov 5, we issued an updated research report on Fastenal Company (FAST).
FAST: 44.47 (-0.06), TREX: 43.88 (-0.12), HOV: 3.98 (+0.21), NVR: 1,227.02 (-7.48)

Louisiana-Pacific Posts Loss in Q3, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:40PM CST
Louisiana-Pacific Corporation (LPX) posted third-quarter 2014 adjusted loss per share of 12 cents against the Zacks Consensus Estimate of 4 cents loss per share.
BCC: 36.45 (-0.98), TREX: 43.88 (-0.12), LPX: 14.69 (+0.04), HOV: 3.98 (+0.21)

Weakness Seen in Louisiana-Pacific Corp (LPX): Stock Falls 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 7:46AM CST
Louisiana-Pacific Corp stock fell nearly 6% last trading session, continuing its recent downtrend
BCC: 36.43 (-1.00), VMC: 65.46 (+0.35), TREX: 43.88 (-0.12), LPX: 14.69 (+0.04)

MasTec Q3 Earnings in Line, Shares Up on Improved Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 12:40PM CST
MasTec's (MTZ) third-quarter earnings were in line with the Zacks Consensus Estimate.
TREX: 43.88 (-0.12), SHW: 236.23 (+0.19), MTZ: 25.50 (-3.13), NVR: 1,227.02 (-7.48)

PGT (PGTI) Misses Q3 Earnings on Increased Material Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 9:30AM CST
PGT, Inc. (PGTI) reported an 8% decline in its Q3 earnings to 12 cents per share, short of the Zacks Consensus Estimate of 13 cents.
PGTI: 9.65 (+0.03), CBPX: 16.83 (-0.04), TREX: 43.88 (-0.12), ROCK: 15.57 (-0.12)

Vulcan Materials Q3 Earnings, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:55PM CST
Vulcan Materials Company's (VMC) third-quarter 2014 adjusted earnings of 54 cents per share beat the Zacks Consensus Estimate by 5.8%.
RH: 78.18 (+0.58), VMC: 65.46 (+0.35), TREX: 43.88 (-0.12), NVR: 1,227.02 (-7.48)

Aegion Corporation (AEGN) Q3 Earnings in Line, Lags Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:00AM CST
Aegion Corporation's (AEGN) Q3 earnings of 43 cents per share declined 2% year-over-year but came in line with the Zacks Consensus Estimate.
CBPX: 16.83 (-0.04), TREX: 43.88 (-0.12), ROCK: 15.57 (-0.12), AEGN: 19.48 (+0.20)

Trex Beats Q3 Earnings on Strong Order Demand, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 2:30PM CDT
Trex's (TREX) third-quarter earnings of 28 cents per share handily beat the Zacks Consensus Estimate.
BCC: 36.43 (-1.00), PGTI: 9.65 (+0.03), TREX: 43.88 (-0.12), SHW: 236.23 (+0.19)

Trex Company to Present at Stephens Fall Investment Conference
Business Wire - Wed Oct 29, 7:30AM CDT
Trex Company, Inc. (NYSE:TREX), the leading manufacturer of wood-alternative decking and railing, today announced it will participate in the Stephens Fall Investment Conference on Tuesday, November 11, 2014.
TREX: 43.88 (-0.12)

Company News for October 28, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 9:10AM CDT
Companies in the News are: BEN,ONB,STNG,TREX
ONB: 14.79 (+0.08), STNG: 8.67 (+0.02), TREX: 43.88 (-0.12), BEN: 56.57 (-0.41)

Trex Co. Inc. (TREX) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 8:11AM CDT
Trex Co. Inc. (TREX) was a big mover last session, as the company saw its shares rise over 6% on the day.
PGTI: 9.65 (+0.03), TREX: 43.88 (-0.12), AIG: 54.14 (+0.11), ADES: 20.51 (+0.14)

Tile Shop Holdings Earnings Preview: 3 Things to Look For
Jason Hall, The Motley Fool - Motley Fool - Mon Oct 27, 5:11PM CDT
Specialty hard-surface retailer Tile Shop Holdings and wood flooring specialist Lumber Liquidators have seen their stocks fall in near-lockstep in 2014: TTS data by YCharts . In many ways, this makes sense. Both companies sell a...
TTS: 8.88 (+0.15), TREX: 43.88 (-0.12), LL: 56.04 (-0.53)

Trex Co. Inc. Q3 Earnings: 3 Reasons Trex Is Just Getting Started
Jason Hall, The Motley Fool - Motley Fool - Mon Oct 27, 12:19PM CDT
Source: Trex. Engineered outdoor decking maker Trex Co. followed up its strong bounce-back second quarter with an even better third quarter. Not only did the company beat its own revenue guidance of $92 million by $3.5 million, but it also beat...
TREX: 43.88 (-0.12)

Trex (TREX) Stock Higher After 2014 Third Quarter Earnings Report
at The Street - Mon Oct 27, 12:05PM CDT
Shares of Trex (TREX) are up after reporting net income of 28 cents per diluted share for the 2014 third quarter, beating analysts' estimates of 24 cents per share.
TREX: 43.88 (-0.12)

Is It Time to Buy Small-Cap Stocks?
Todd Campbell, The Motley Fool - Motley Fool - Mon Oct 27, 12:01PM CDT
The Russell 2000 index is the most widely embraced measure of small-cap performance, and its returns this year have been downright dismal. So far, the iShares Russell 2000 ETF has tumbled more than 11% in 2014, prompting some to speculate that the...
SPY: 203.89 (+0.55), CAMP: 19.47 (-0.23), TREX: 43.88 (-0.12), QSII: 14.58 (+0.02), IWM: 116.74 (+0.03)

Trex Company Announces Record Third-Quarter Sales and EPS
Business Wire - Mon Oct 27, 6:30AM CDT
--EPS increases to $0.28
TREX: 43.88 (-0.12)

Trex Co. Inc. Earnings: 3 Things to Look For
Jason Hall, The Motley Fool - Motley Fool - Fri Oct 24, 4:01PM CDT
Expect an update on the polyethylene extrusion business on Monday. Source: Lluis tgn via Wikimedia Commons. Trex has been one of the few bright spots in the home remodeling products business over the past few months. While the stock is down...
TTS: 8.88 (+0.15), TREX: 43.88 (-0.12), LL: 56.04 (-0.53)

Trex(R) Announces New Aluminum Gate and ADA-Compliant Handrails
Marketwired - Wed Oct 22, 8:08AM CDT
Trex Company, the world's largest manufacturer of high-performance wood-alternative decking and railing, announced the expansion of its railing portfolio with the introduction of two new offerings. Rounding out the Trex railing line are sturdy and stylish aluminum gates and new Americans with Disabilities Act (ADA)-compliant secondary handrails. Designed to seamlessly blend with all Trex railing options, the new gates and handrails offer an extra level of safety, strength and accessibility for any deck design.
TREX: 43.88 (-0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...